Log In
Friday 25th May 2018

Alzheimer's warning

12th October 2006

09082006_alzheimers1.jpgHealthworkers fear the ban on drugs to treat Alzheimer’s disease will lead to a rise in use of potentially dangerous sedatives.

Despite sustained arguments for their use, the National Institute for Clinical Excellence (NICE) upheld its decision against the use of three acetlycholinesterase inhibitors; donezepil, galantamine and rivastigmine for mild forms of the disease, and memantine for advanced stages of Alzheimer's.

Now the Royal College of Nursing (RCN) has warned that the ban will leave healthworkers with no other choice but to increase use of sedatives and predicted it would increase the cost of caring for these people who would need long term care much earlier than if they were given drugs to delay the onset of the disease.  


Share this page


There are no comments for this article, be the first to comment!

Post your comment

Only registered users can comment. Fill in your e-mail address for quick registration.

Your email address:

Your comment will be checked by a Healthcare Today moderator before it is published on the site.

Mayden - Innovative cloud-based applications for healthcare
© Mayden Foundation 2018